ABBOTT PARK, Ill., July 11, 2019 /PRNewswire/ -- Abbott (NYSE: ABT) announced today U.S. Food and Drug Administration (FDA) approval for its new blood and plasma screening Alinity™ s System. This new ...
-- Abbott's Alinity™ m Resp-4-Plex assay will allow healthcare workers to test for four viruses in one test, a critically important tool as flu presents with similar symptoms -- The test helps save on ...
How important are diagnostic tests in clinical decision making? Diagnostic tests are critical as up to 60 to 70% of critical clinical decisions are influenced by diagnostic test results. It's of huge ...
Abbott has received US Food and Drug Administration (FDA) approval for its molecular human papillomavirus or HPV screening solution, adding a powerful cancer screening tool for detecting high-risk HPV ...
Abbott Laboratories is adding HPV screening to its "Alinity m" family of diagnostic assays following U.S. Food & Drug Administration approval. Abbott said in a press release that the FDA approved its ...
The International Monetary Fund said on Friday it approved about $348.5 million in funding for the Democratic Republic of Congo after completing reviews of programs under its Extended Credit ...
Abbott Laboratories received FDA emergency use authorization (EUA) for its COVID-19 molecular test, which will run on the company's new Alinity m system, as well as its COVID-19 antibody blood test, ...
Abbott announced that the US Food and Drug Administration (FDA) approval for its new blood and plasma screening Alinity s System. This new solution will bring the latest screening technology to US ...
As global healthcare changes, healthcare institutions are being tasked with handling a higher volume of patients, rising costs, and heightened performance pressures. Laboratories, in particular, are ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results